Role of organic and ceramic biomaterials on bone healing and regeneration: An experimental study with significant value in translational tissue engineering and regenerative medicine

سال انتشار: 1399
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 247

فایل این مقاله در 13 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-23-11_009

تاریخ نمایه سازی: 19 دی 1399

چکیده مقاله:

Objective(s): We investigated the role of various biomaterials on cell viability and in healing of an experimentally induced femoral bone hole model in rats.Materials and Methods: Cell viability and cytotoxicity of gelatin (Gel; 50 µg/µl), chitosan (Chi; 20 µg/µl), hydroxyapatite (HA; 50 µg/µl), nanohydroxyapatite (nHA; 10 µg/µl), three-calcium phosphate (TCP; 50 µg/µl) and strontium carbonate (Sr; 10 µg/µl) were evaluated on hADSCs via MTT assay. In vivo femoral drill-bone hole model was produced in rats that were either left untreated or treated with autograft, Gel, Chi, HA, nHA, TCP and Sr, respectively. The animals were euthanized after 30 days. Their bone holes were evaluated by gross-pathology, histopathology, SEM and radiography. Also, their dry matter, bone ash and mineral density were measured.Results: Both the Gel and Chi showed cytotoxicity, while nHA had no role on cytotoxicity and cell-viability. All the HA, TCP and Sr significantly improved cell viability when compared to controls (p <0.05). Both the Gel and Chi had no role on osteoconduction and osteoinduction. Compared to HA, nHA showed superior role in increasing new bone formation, mineral density and ash (p <0.05). In contrast to HA and nHA, both the TCP and Sr showed superior morphological, radiographical and biochemical properties on bone healing (p <0.05). TCP and Sr showed the most effective osteoconduction and osteoinduction, respectively. In the Sr group, the most mature type of osteons formed.Conclusion: Various biomaterials have different in vivo efficacy during bone regeneration. TCP was found to be the best material for osteoconduction and Sr for osteoinduction.

نویسندگان

Ali Moshiri

Razi Drug Research Center, and department of Pharmacology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Neda Tekyieh Maroof

Razi Drug Research Center, and department of Pharmacology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Ali Mohammad Sharifi

Razi Drug Research Center, and department of Pharmacology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • 1. Oryan A, Alidadi S, Moshiri A, Maffulli N. Bone ...
  • 2. Oryan A, Alidadi S, Moshiri A. Platelet-rich plasma for ...
  • 3. Oryan A, Alidadi S, Moshiri A, Bigham-Sadegh A. Bone ...
  • 4. Moshiri A, Sharifi AM, Oryan A. Current knowledge, drug-based ...
  • 5. Moshiri A, Sharifi AM, Oryan A. Role of Simvastatin ...
  • 6. Moshiri A, Shahrezaee M, Shekarchi B, Oryan A, Azma ...
  • 7. Mobini S, Taghizadeh-Jahed M, Khanmohammadi M, Moshiri A, Naderi ...
  • 8. Perez RA, Mestres G. Role of pore size and ...
  • 9. Li L, He ZY, Wei XW, Wei YQ. Recent ...
  • 10. Curry AS, Pensa NW, Barlow AM, Bellis SL. Taking ...
  • 11. Oryan A, Kamali A, Moshiri A. Potential mechanisms and ...
  • 12. Chen C, Bang S, Cho Y, Lee S, Lee ...
  • 13. Narayanan G, Vernekar VN, Kuyinu EL, Laurencin CT. Poly ...
  • 14. Tang D, Tare RS, Yang LY, Williams DF, Ou ...
  • 15. Poinern GE, Brundavanam RK, Thi Le X, Nicholls PK, ...
  • 16. Amjadian S, Seyedjafari E, Zeynali B, Shabani I. The ...
  • 17. Rodriguez IA, Saxena G, Hixon KR, Sell SA, Bowlin ...
  • 18. Pangon A, Saesoo S, Saengkrit N, Ruktanonchai U, Intasanta ...
  • 19. Shavandi A, Bekhit AE, Sun Z, Ali MA. Bio-scaffolds ...
  • 20. Li Z, Kawashita M. Current progress in inorganic artificial ...
  • 21. Mazaheri M, Eslahi N, Ordikhani F, Tamjid E, Simchi ...
  • 22. Cheng H, Xiong W, Fang Z, Guan H, Wu ...
  • 23. Tsuji W, Schnider JT, McLaughlin MM, Schweizer R, Zhang ...
  • 24. Choi YS, Dusting GJ, Stubbs S, Arunothayaraj S, Han ...
  • 25. Ardeshirylajimi A, Soleimani M, Hosseinkhani S, Parivar K, Yaghmaei ...
  • 26. Oryan A, Moshiri A, Meimandi-Parizi A. Implantation of a ...
  • 27. Moshiri A, Oryan A, Meimandi-Parizi A. Role of tissue-engineered ...
  • 28. Meimandi-Parizi A, Oryan A, Moshiri A. Tendon tissue engineering ...
  • 29. Oryan A, Moshiri A. Recombinant fibroblast growth protein enhances ...
  • 30. Moshiri A, Oryan A, Meimandi-Parizi A. Synthesis, development, characterization ...
  • 31. Wan W, Zhang S, Ge L, Li Q, Fang ...
  • 32. Jin Y, Zhang W, Liu Y, Zhang M, Xu ...
  • 33. Dufrane D, Docquier PL, Delloye C, Poirel HA, Andre ...
  • 34. Yoon D, Kang BJ, Kim Y, Lee SH, Rhew ...
  • 35. Rampino A, Borgogna M, Blasi P, Bellich B, Cesaro ...
  • 36. Habraken WJ, Wolke JG, Jansen JA. Ceramic composites as ...
  • 37. Habibovic P, de Groot K. Osteoinductive biomaterials--properties and relevance ...
  • 38. Surmeneva MA, Kleinhans C, Vacun G, Kluger PJ, Schonhaar ...
  • 39. Lim HC, Kim KT, Lee JS, Jung UW, Choi ...
  • 40. Thakare K, Deo V. Randomized controlled clinical study of ...
  • 41. Annibali S, Iezzi G, Sfasciotti GL, Cristalli MP, Vozza ...
  • 42. Sakai S, Anada T, Tsuchiya K, Yamazaki H, Margolis ...
  • 43. Bellucci D, Sola A, Cannillo V. Hydroxyapatite and tricalcium ...
  • 44. Liu J, Zhao L, Ni L, Qiao C, Li ...
  • 45. Park JW, Kang DG, Hanawa T. New bone formation ...
  • 46. Machado CP, Sartoretto SC, Alves AT, Lima IB, Rossi ...
  • 47. Liu J, Rawlinson SC, Hill RG, Fortune F. Strontium-substituted ...
  • نمایش کامل مراجع